Measuring Timeliness of Outbreak Response in the World Health Organization African Region, 2017-2019.

Integrated Disease Surveillance and Response strategy WHO African Region WHO Health Emergencies Programme World Health Organization communicable diseases disease outbreaks foodborne diseases internally-displaced populations outbreak response refugee populations time to control time to detection time to notification vaccine-preventable diseases vector-borne diseases waterborne diseases

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
11 2020
Historique:
entrez: 20 10 2020
pubmed: 21 10 2020
medline: 16 6 2021
Statut: ppublish

Résumé

Large-scale protracted outbreaks can be prevented through early detection, notification, and rapid control. We assessed trends in timeliness of detecting and responding to outbreaks in the African Region reported to the World Health Organization during 2017-2019. We computed the median time to each outbreak milestone and assessed the rates of change over time using univariable and multivariable Cox proportional hazard regression analyses. We selected 296 outbreaks from 348 public reported health events and evaluated 184 for time to detection, 232 for time to notification, and 201 for time to end. Time to detection and end decreased over time, whereas time to notification increased. Multiple factors can account for these findings, including scaling up support to member states after the World Health Organization established its Health Emergencies Programme and support given to countries from donors and partners to strengthen their core capacities for meeting International Health Regulations.

Identifiants

pubmed: 33079032
doi: 10.3201/eid2611.191766
pmc: PMC7588517
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2555-2564

Références

Health Secur. 2017 Mar/Apr;15(2):215-220
pubmed: 28384035
BMJ Glob Health. 2019 Jul 3;4(4):e001427
pubmed: 31354972
Pan Afr Med J. 2019 May 29;33(Suppl 2):7
pubmed: 31402966
Vaccine. 2020 Feb 29;38 Suppl 1:A13-A17
pubmed: 31326254
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21701-6
pubmed: 21115835
BMC Public Health. 2015 May 01;15:448
pubmed: 25928645
Emerg Infect Dis. 2016 Oct;22(10):E1-6
pubmed: 27649306
Int Marit Health. 2017;68(3):163-167
pubmed: 28952662
Hum Vaccin Immunother. 2016 Oct 2;12(10):2690-2693
pubmed: 27541082
Epidemiol Infect. 2019 Nov 11;147:e299
pubmed: 31709961
Health Policy Plan. 2019 Feb 1;34(1):47-54
pubmed: 30624680
BMC Proc. 2017 Jan 31;11(Suppl 1):2
pubmed: 28813542
Lancet. 2006 May 27;367(9524):1747-57
pubmed: 16731270
PLoS One. 2017 Mar 10;12(3):e0173346
pubmed: 28282397

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH